chr19-2717686-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_145173.4(DIRAS1):c.121G>A(p.Glu41Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,459,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_145173.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DIRAS1 | NM_145173.4 | c.121G>A | p.Glu41Lys | missense_variant | 2/2 | ENST00000323469.5 | NP_660156.1 | |
DIRAS1 | XM_047438274.1 | c.223G>A | p.Glu75Lys | missense_variant | 3/3 | XP_047294230.1 | ||
DIRAS1 | XM_047438275.1 | c.223G>A | p.Glu75Lys | missense_variant | 3/3 | XP_047294231.1 | ||
DIRAS1 | XM_047438276.1 | c.223G>A | p.Glu75Lys | missense_variant | 3/3 | XP_047294232.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DIRAS1 | ENST00000323469.5 | c.121G>A | p.Glu41Lys | missense_variant | 2/2 | 1 | NM_145173.4 | ENSP00000325836.3 | ||
DIRAS1 | ENST00000585334.1 | c.121G>A | p.Glu41Lys | missense_variant | 1/1 | 6 | ENSP00000468417.1 | |||
DIRAS1 | ENST00000588128.1 | c.121G>A | p.Glu41Lys | missense_variant | 3/3 | 4 | ENSP00000466733.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1459800Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 726274
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2024 | The c.121G>A (p.E41K) alteration is located in exon 2 (coding exon 1) of the DIRAS1 gene. This alteration results from a G to A substitution at nucleotide position 121, causing the glutamic acid (E) at amino acid position 41 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.